v3.26.3
BALANCE SHEET COMPONENTS - Schedule of Accrued Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Balance Sheet Components [Abstract]    
Accrued compensation expenses $ 41,468 $ 36,299
Accrued clinical studies and research and development expenses 14,264 15,656
Accrued legal and professional service expenses 5,267 3,650
Accrued marketing expenses 4,819 712
Accrued other expenses 10,487 7,628
Total accrued liabilities $ 76,305 $ 63,945